# FDA EIR - C S Bio Co. - February 17, 2022

Source: https://www.globalkeysolutions.net/records/eir/c-s-bio-co/168b0164-6aa4-4b21-8fc0-19cffe23088b

> FDA EIR for C S Bio Co. on February 17, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: C S Bio Co.
- Inspection Date: 2022-02-17
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/c-s-bio-co/c26b6bb7-b34e-49ea-af72-ba1b0b0d6b59)

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/simon-chen/0d228e1f-c493-41d5-be29-1d726567aa60)
- [company_representative](https://www.globalkeysolutions.net/people/zoe-h-liang/1bdbed52-7b56-4100-9f1a-35e8fa5d1361)
- [recipient](https://www.globalkeysolutions.net/people/jason-y-chang/31f7272c-30c3-4f35-85ea-96785d4a622b)
- [National Program Expert- Pharmacy Compounding](https://www.globalkeysolutions.net/people/lucila-b-nwatu/3d1c9670-8206-425c-bddd-32e395293042)
- [Investigator](https://www.globalkeysolutions.net/people/jolanna-a-norton/5501fea4-4bfd-434c-b2aa-fcf94444f684)

Company: https://www.globalkeysolutions.net/companies/c-s-bio-co/a9fc98b7-4f08-4e80-a2d7-f61ec1043b10

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6